Hematological Adverse Effects in HCV Patients Treated With Pegylated Interferon and Ribavirin in a Tertiary Care Hospital Peshawar. mfm. 2024;26(3). Accessed July 26, 2026. http://medicalforummonthly.com/index.php/mfm/article/view/2736